Indian Subcontinent All Cap

Rizi Mohanty is a Portfolio Manager at FSSA Investment Managers. He joined the team in 2016 and focuses on the Southeast Asian markets as well as Asia ex-Japan equities more broadly. He is the lead manager of the FSSA ASEAN All Cap and FSSA Asian Growth strategies. Rizi has more than 14 years of investment experience and is based in Hong Kong. 

Sree and Rizi are supported by a broader team of investment analysts, with an average of 16 years of investment experience and 8 years tenure with the team. All 15 members of the FSSA investment team are analysts first and foremost, including the portfolio managers, and we spend the majority of our time meeting companies, writing research and seeking quality companies to invest in.

How we invest

FSSA’s investment philosophy, which shares its genesis with SI, has remained broadly unchanged since the First State Stewart team was established in 1988. We focus on identifying quality companies, buying them at a sensible price and holding them for the long term. Most importantly, we invest our clients’ capital as if it were our own. As long-term investors and owners of businesses on behalf of our clients, we look for founders and management teams that act with integrity and risk awareness, and dominant franchises that have the ability to deliver sustainable and predictable returns over the long term.

As a team, we conduct over 1,000 direct company meetings each year across Asia and other emerging markets. The most significant source of investment ideas comes from these company visits and country research trips. We find that our reputation as patient, long-term investors has given us unparalleled access to management, which allows us to gain valuable insights and a thorough understanding of the businesses we want to invest in.

As a result of our long-term time horizon and conservative investment approach, our portfolios – and our performance – can look very different to the index. We shy away from “flavour of the month” themes (such as the current AI-driven boom), and instead look for high-quality companies that can deliver attractive returns for much longer than the market expects – and extend our investment time horizon to capture that advantage. When you own quality businesses, time isn’t a risk – it’s an asset.

Our performance may lag in very buoyant or momentum-driven markets, but we usually compensate very quickly once such bubbles burst. Based on historical data, our long-term track record shows that our portfolios tend to perform better in “normal” markets (-15% to +15% 1-year rolling returns) and bear markets (more than 15% decline), than in steeply rising markets (defined as over 15% 1-year rolling returns).

A smooth transition

Given the significant overlap in SI’s and FSSA’s investment philosophy and portfolios, we know all the holdings well. As part of the transition, we made a few changes to tilt the portfolio towards companies with stronger cash generation, higher returns and better long-term growth prospects.

Below, we highlight a few of the key additions and disposals over the fourth quarter of 2025.

New purchases:

Kotak Mahindra Bank (KMB) is one of India’s leading financial services companies – it has consistently improved the strength of its deposit franchise and maintained better asset quality than peers through the business cycle. While the founder, Uday Kotak, has stepped down from his managing director/CEO role due to the central bank’s limits on leadership terms, he remains closely involved as a board director and should ensure that the bank’s risk awareness and long-term thinking is maintained. Meanwhile, the new CEO (Ashok Vaswani) aspires to grow the business further by focusing on consumer banking and digitisation. We expect to see a growing trend of formalised financial savings, benefiting KMB’s insurance, mutual funds and asset management businesses.

KEI Industries is a leading cables and wires company. The company started as an institutional / tender business, which evolved into a diversified retail franchise. The track record of growth and returns on capital employed has been solid, while customer concentration has reduced and cash conversion has improved. Now, it is focusing on executing the next stage of growth – high-voltage cables and exports. We believe the quality of the business has improved significantly in recent years, and it still has room to grow.

Bosch India is a leading auto-components manufacturer. It was the market leader in fuel injection systems in India, developing new technologies to meet the increasingly stringent Bharat Stage (BS) emission standards in India. This enabled Bosch to maintain its dominant place in the industry (45% - 85% market share across various internal combustion engine (ICE) segments) over several decades. Today, Bosch has evolved to become one of the world’s top EV-component manufacturers. Under the leadership of the new CEO, Bosch is starting to gain market share and improve margins in this space. Bosch globally has invested over €10bn in EV development and maintains significant manufacturing and engineering capacity, including the largest pool of EV engineers in India. We believe it is well positioned for the ongoing EV transition, and it should benefit from rising auto penetration in India – regardless of which auto manufacturer dominates.

Complete sales:

Motilal Oswal Financial Services is a non-bank financial company (NBFC) in India. We sold out of a lower conviction holding to raise cash for better ideas elsewhere.

KPIT Technologies is an Engineering Research & Development company focused on the automotive sector. We sold on account of its expensive valuations and concerns about headwinds for its key customers after a strong period of growth.

CG Power & Industrial makes transformers that are used in power and industrial applications. We believe it is expensively valued for a cyclical business.

Performance and outlook

With our long-term investment time horizon, we tend not to pay much attention to short-term market fluctuations. We invest on at least a three-to-five-year view, though we often hold on to companies for much longer. In an industry rife with short-termism, we believe our long-term approach stands out from the crowd.

What we have seen, over the past few decades, is that average holding periods for stocks have fallen from over eight years in the 1960s to less than six months today.  Yet this shift has come at a cost: it reduces investors’ ability to generate outsized returns that are materially different from the broader market. The reason is simple — as investment horizons shrink, so does the return dispersion between the best- and worst-performing companies. With less time in the market, investors end up tracking the index, not beating it.

Emerging Markets: time horizons matter

MSCI EM Index -dispersion around mean return for top 10% top / bottom stock performers

Although we recognise the impact that these concerns have had on investor sentiment towards the Indian market, we continue to view the country as a compelling destination for long-term investors. Focusing too narrowly on short-term returns risks overlooking the compelling returns that many of our investments in India have generated over the past five-to-10 years. We believe investing in high-quality companies addressing the sustainable growth needs of India should generate good returns over the years to come. In particular, we continue to be excited by companies that are seeking to meet growing domestic demand.

Activity

This quarter, we re-established a position in Tata Consultancy Services (Information Technology). Its shares have fallen by almost a third since the end of 2024.¹ Recent increases in the cost of H-1B visas, which US companies use to hire foreign workers – including India’s IT specialists – further weakened sentiment. We continue to believe this well-managed business is a critically important partner for many global companies.

We also bought Mankind Pharma (Health Care), which is known for providing affordable healthcare. We first met this company a year ago during a research trip to India and have developed our understanding of further it over the last 12 months. Mankind’s operations span pharmaceuticals, consumer healthcare, and over-the-counter (OTC) medicines. It also has a particularly strong presence in rural India and in the country’s smaller cities.

We sold our positions in Tata Communications (Communication Services) and Dr. Reddy’s Laboratories (Health Care). Our belief in the strength of their franchises had faded. And the opportunity cost of holding them relative to our stronger investment ideas had increased. We also completed the sale of VST Tillers Tractors (Industrials), which faces increasingly tough competition from cut-price imports.

[1] Source: S&P Capital IQ as of 30 September 2025.

Blue Star (India: Industrials) makes, installs and services air conditioners, refrigerators, deep freezers, watercoolers, and cold rooms. Its products are found in a third of India’s commercial buildings¹. The final addition, MakeMyTrip (India: Consumer Discretionary), is India’s leading online travel agency. Its platforms – MakeMyTrip, Goibibo and redBus – facilitate travel and tourism, supporting job creation and economic growth.

To fund these additions, we sold Syngene (India: Health Care), Cyient (India: Information Technology), Dr. Lal PathLabs (India: Health Care), Bajaj Housing Finance (India: Financials), Tata Chemicals (India: Materials) and Tata Consumer Products (India: Consumer Staples). These sales were prompted either by valuations becoming too stretched or because we felt the opportunity cost of holding these positions was too high given the strength of our confidence in other stocks.

Focusing on what individual companies are saying and doing is especially important amid distractions offered by profusion of short-term news on the global economy, trade and geopolitics. Although we understand that the companies whose shares we own do not exist in a vacuum, we try to focus on what we can control rather than fretting over those things we can’t. As such, we are striving to analyse the long-term opportunities and risks that are particular to the companies we invest in.

[1] Source: Blue Star Annual Report 2023-24. 

The fall in the Indian market in recent months should be seen in the context of the strong returns that it has generated in recent years. Furthermore, equities typically deliver returns over the long term, so we continue to focus on the long-term growth potential of the companies we own. We have made three research visits to India over the past four months and remain excited by the opportunities we find there.